Brief: Lineage Cell Therapeutics Announces Early Exercise Of Option With Cancer Research UK For Immuno-Oncology Cell Therapy Program

Lineage Cell Therapeutics

07/05/2020 13:51

May 7 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE CELL THERAPEUTICS ANNOUNCES EARLY EXERCISE OF
OPTION
WITH CANCER RESEARCH UK FOR IMMUNO-ONCOLOGY CELL THERAPY PROGRAM
    * LINEAGE CELL THERAPEUTICS INC - LINEAGE WILL ASSUME
RESPONSIBILITY FOR FURTHER DEVELOPMENT OF VAC2 PRODUCT CANDIDATE
    * LINEAGE CELL THERAPEUTICS INC -  LINEAGE WILL ASSUME
RESPONSIBILITY FOR FUTURE DEVELOPMENT OPPORTUNITIES DERIVED FROM
VAC PLATFORM
    * LINEAGE CELL THERAPEUTICS INC - CANCER RESEARCH UK WILL
PROVIDE
INPUT ON POTENTIAL USE OF VAC IN INFECTIOUS DISEASE SPACE TO
DEVELOP A VACCINE AGAINST SARS-COV-2

Source text for Eikon:  ID:nBw2pwHLMa 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))